Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 250 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Guillermo L.

Germany

USD 250 /hr

Chief Scientific Officer for spin-off Fluorizon

Profile Summary

Fluorizon is a contract research organisation (CRO) which provides services for the preparation and preclinical evaluation of radiolabeled molecules (radiopharmaceuticals) to international (radio)pharmaceutical companies. Fluorizon’s unique radiolabeling technology allows molecules (e.g. drug candidates) to be rapidly radiolabeled in high yields. Molecular radiolabeling allows customers to gain key insights into how their molecules perform in cellular assays or in small animal models. The data we provide to customers can be used for radiopharmaceutical development and to accelerate drug development pipelines. What we offer: - Molecular Radiolabeling: We can transform molecules into radiopharmaceuticals with a variety of radionuclides depending on the desired application. Radionuclides including copper-64, fluorine-18, gallium-68, lutetium-177 and iodine-123 are readily available for the radiolabeling of molecules. - In vitro Assays: Radiopharmaceutical stability, specificity and binding to a biological target can be evaluated using a number of cellular assays. Real-time binding experiments using radiopharmaceuticals on live cells can be used to determine the binding mechanism, affinity and kinetics. - In vivo Experiments: Following in vitro validation, a radiopharmaceutical may be visualized using PET or SPECT imaging in a small animal model. Pharmacokinetics (PK) and biodistribution (ADME) studies may be performed using clinically healthy mice. More complex tumor models may also be considered on demand. Lets discuss your specific needs and see if radiolabeling is a viable option for you!

Subject Matter Expertise

• ★ Chemistry
• ★ Preclinical ADME/PK/PD
• ★ Preclinical Pharmacology
• ☆ Radiochemistry
• ☆ Green Chemistry
• ☆ Biology/Life Sciences
• ☆ Biochemistry
• ☆ Medicinal Chemistry
• ☆ Drug Development
• ☆ Preclinical Research

Services

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Non-Medical Regulatory Writing, Technical Writing

Research Market Research, User Research, Meta-Research, Feasibility Study, Fact Checking, Gap Analysis, Systematic Literature Review

Consulting Scientific and Technical Consulting

Data & AI Statistical Analysis, Image Processing

Product Development Stability/Shelf Life Testing, Product Evaluation, Product Validation

Work Experience

Chief Scientific Officer

Fluorizon

July 2023 - Present

Ph.D Student

Helmholtz-Zentrum Dresden-Rossendorf

February 2017 - September 2021

Education

Ph.D. in Biology (Institute of biological sciences)

TU Bergakademie Freiberg

February 2017 - Present

MSc Biotechnology (Engineering and Physical Sciences)

Heriot-Watt University

September 2015 - September 2016

BSc(Hons) Chemistry with Pharmaceutical Chemistry (Engineering and Physical Sciences)

Heriot-Watt University

September 2011 - June 2015

Certifications

• FELASA function B "Designing of procedures and projects"

  Humboldt-Universität zu Berlin

  May 2024 - Present

• FELASA / Laboratory animal science Functions A, D

  Humboldt-Universität zu Berlin

  August 2023 - Present

• STATSx: Statistics: Unlocking the World of Data

  EdinburghX (EdX)

  https://courses.edx.org/certificates/7a9abc3fef5a41e68c0eff39ff02188c

  March 2022 - Present

• Pharmacology

  CPD Certification

  March 2022 - Present

Publications

JOURNAL ARTICLE

Sergio Gonzalez-Poggini and Guillermo Luque Consuegra and Willy Kracht and Martin Rudolph and Melanie Colet-Lagrille(2021). Electrochemical Characterization of Sulphide Minerals–Halophilic Bacteria Surface Interaction for Bioflotation Applications . Metallurgical and Materials Transactions B. 52. (5). p. 3373--3382. Springer Science and Business Media {LLC}

Guillermo Luque Consuegra, Sabine Kutschke, Martin Rudolph, Katrin Pollmann(2020). Halophilic bacteria as potential pyrite bio-depressants in Cu-Mo bioflotation . Minerals Engineering. 145. p. 106062. Elsevier {BV}